Search

Author/Creator Brenton, James

1. 2022-RA-1058-ESGO Developing infrastructure for molecular profiling for all in ovarian cancer (DEMO). (20th October 2022)

Authors:
Leung, Elaine; Funingana, Gabriel; Bird, Lisa; Alcaraz, Marie-Lyne; Ang, Joo Ern; Parkinson, Christine; Jimenez-Linan, Merche; Freeman, Sue; Spencer, Catherine; Winning, Julie; Ganesan, Raji; Williams, Sarah; Ong, Kai Ren; Abedin, Parveen; Boyle, William; Sundar, Sudha; Balega, Janos; Brenton, James
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A292
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Issue 1 (December 2016)

Authors:
Ali, H.; Dariush, Aliakbar; Provenzano, Elena; Bardwell, Helen; Abraham, Jean; Iddawela, Mahesh; Vallier, Anne-Laure; Hiller, Louise; Dunn, Janet.; Bowden, Sarah; Hickish, Tamas; McAdam, Karen; Houston, Stephen; Irwin, Mike; Pharoah, Paul; Brenton, James; Walton, Nicholas; Earl, Helena; Caldas, C...
Journal:
Breast cancer research
Issue:
Volume 18:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. EP361/#717 Developing infrastructure for molecular profiling in ovarian cancer (DEMO). (4th December 2022)

Authors:
Leung, Elaine; Funingana, Gabriel; Bird, Lisa; Alcaraz, Marie-Lyne; Ang, Joo Ern; Parkinson, Christine; Jimenez-Linan, Merche; Freeman, Sue; Spencer, Catherine; Winning, Julie; Ganesan, Raji; Williams, Sarah; Ong, Kai Ren; Abedin, Parveen; Boyle, William; Sundar, Sudha; Balega, Janos; Brenton, James
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 3
Page Start:
A201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer. Issue 6 (July 2015)

Authors:
Sayal, Karen; Gounaris, Ioannis; Basu, Bristi; Freeman, Sue; Moyle, Penny; Hosking, Karen; Iddawela, Mahesh; Jimenez-Linan, Mercedes; Abraham, Jean; Brenton, James; Hatcher, Helen; Earl, Helena; Parkinson, Christine
Journal:
International journal of gynecological cancer
Issue:
Volume 25:Issue 6(2015:Jul.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study. Issue 6 (1st July 2015)

Authors:
Sayal, Karen; Gounaris, Ioannis; Basu, Bristi; Freeman, Sue; Moyle, Penny; Hosking, Karen; Iddawela, Mahesh; Jimenez-Linan, Mercedes; Abraham, Jean; Brenton, James; Hatcher, Helen; Earl, Helena; Parkinson, Christine
Journal:
International journal of gynecological cancer
Issue:
Volume 25:Issue 6(2015:Jul.)
Page Start:
977
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer. Issue 5 (16th June 2020)

Authors:
Song, Honglin; Dicks, Ed M; Tyrer, Jonathan; Intermaggio, Maria; Chenevix-Trench, Georgia; Bowtell, David D; Traficante, Nadia; Group, AOCS; Brenton, James; Goranova, Teodora; Hosking, Karen; Piskorz, Anna; van Oudenhove, Elke; Doherty, Jen; Harris, Holly R; Rossing, Mary Anne; Duerst, Matthias; ...
Journal:
Journal of medical genetics
Issue:
Volume 58:Issue 5(2021)
Page Start:
305
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access. Issue 6 (24th May 2017)

Authors:
Shipman, Hannah; Flynn, Samantha; MacDonald‐Smith, Carey F; Brenton, James; Crawford, Robin; Tischkowitz, Marc; Hulbert‐Williams, Nicholas J
Journal:
Journal of genetic counseling
Issue:
Volume 26:Issue 6(2017)
Page Start:
1280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial. Issue 7 (July 2022)

Authors:
Clamp, Andrew R; James, Elizabeth C; McNeish, Iain A; Dean, Andrew; Kim, Jae-Won; O'Donnell, Dearbhaile M; Gallardo-Rincon, Dolores; Blagden, Sarah; Brenton, James; Perren, Tim J; Sundar, Sudha; Lord, Rosemary; Dark, Graham; Hall, Marcia; Banerjee, Susana; Glasspool, Rosalind M; Hanna, C Louise; ...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 7(2022)
Page Start:
919
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗